DF Dent & Co’s West Pharmaceutical WST Stock Holding History

DF Dent & Co’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.2M	Sell	120,597 -198,985	-62%	-$49.5M	0.58%	52
2025 Q4	$87.9M	Sell	319,582 -64,123	-17%	-$17.5M	1.27%	28
2025 Q3	$101M	Sell	383,705 -11,569	-3%	-$2.81M	1.3%	28
2025 Q2	$86.5M	Sell	395,274 -44,024	-10%	-$9.41M	1.1%	31
2025 Q1	$98.3M	Buy	439,298 +42,202	+11%	+$11.6M	1.31%	30
2024 Q4	$130M	Sell	397,096 -56	-0%	-$17.6K	1.65%	25
2024 Q3	$119M	Buy	397,152 +98,564	+33%	+$30.2M	1.45%	26
2024 Q2	$98.4M	Buy	298,588 +38,654	+15%	+$13.7M	1.27%	29
2024 Q1	$103M	Buy	259,934 +182,443	+235%	+$67.5M	1.26%	30
2023 Q4	$27.3M	Sell	77,491 -1,789	-2%	-$633K	0.36%	55
2023 Q3	$29.7M	Sell	79,280 -466	-0.6%	-$180K	0.44%	52
2023 Q2	$30.5M	Buy	79,746 +2,902	+4%	+$1.04M	0.41%	54
2023 Q1	$26.6M	Sell	76,844 -307	-0.4%	-$89.7K	0.38%	52
2022 Q4	$18.2M	Buy	+77,151	New	+$18.3M	0.27%	58

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DF Dent & Co's WST Position: Q1 2026 in Review

DF Dent & Co reduced its West Pharmaceutical (WST) stake by 62% in Q1 2026, selling an estimated $49.5M and leaving 120,597 shares worth $30.2M. The position accounts for 0.58% of the portfolio, ranked #52.

DF Dent & Co first reported a position in WST in Q4 2022 and has held it in 14 quarters since. The position peaked at $130M in Q4 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

DF Dent & Co held 120,597 shares of West Pharmaceutical worth $30.2M as of Q1 2026.
DF Dent & Co sold 198,985 West Pharmaceutical shares in Q1 2026, an estimated $49.5M.
West Pharmaceutical made up 0.58% of DF Dent & Co's portfolio in Q1 2026, its #52 holding.
DF Dent & Co first reported a position in West Pharmaceutical in Q4 2022 and has held it in 14 quarters since.
DF Dent & Co's West Pharmaceutical position peaked at $130M in Q4 2024.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on DF Dent & Co's 13F filing for Q1 2026, filed 15 May 2026.